Voltage-gated sodium and potassium channels (VGSC/VGKC)

Voltage-gated sodium (NaV) and potassium (KV) channels are specialized transmembrane proteins that play a fundamental role in the electrical excitability of cells within the nervous, muscular, and cardiovascular systems. NaV channels facilitate the rapid influx of sodium ions, which triggers the depolarization phase of the action potential, while KV channels allow the efflux of potassium ions to mediate repolarization and maintain the resting membrane potential (Catterall, 2012, J Physiol). These channels are critical pharmacological targets for treating various disorders, including epilepsy, cardiac arrhythmias, and chronic pain (Wulff et al., 2009, Nat Rev Drug Discov). Therapeutic agents typically function by blocking the channel pore or modulating the gating mechanism to alter the threshold or duration of electrical signaling. However, because these channels are widely expressed throughout the body, achieving subtype selectivity is a major challenge in drug development to minimize adverse effects such as cardiotoxicity or neurotoxicity (StatPearls, 2023). Mutations in the genes encoding these channels, known as channelopathies, are linked to a variety of inherited diseases, further highlighting their physiological importance. Overall, they represent a diverse and vital class of therapeutic targets in modern medicine.

Other names

Voltage-dependent sodium and potassium channelsVoltage-dependent sodium channelsVoltage-dependent potassium channelsNaV and KV channelsVoltage-gated ion channels

Drugs targeting these channels typically act by physically blocking the ion-conducting pore (pore blockers) or by binding to allosteric sites to modulate gating transitions, such as stabilizing the inactivated state to reduce cellular excitability (Catterall, 2012; Wulff et al., 2009).